Page last updated: 2024-08-23

diaziquone and Leukemia, Myeloid

diaziquone has been researched along with Leukemia, Myeloid in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19901 (16.67)18.7374
1990's2 (33.33)18.2507
2000's3 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baer, MR; Block, AW; Bloomfield, CD; Carroll, AJ; Farag, SS; Koduru, PR; Kolitz, JE; Larson, RA; Mayer, RJ; Moore, JO; Mrózek, K; Pettenati, MJ; Powell, BL; Ruppert, AS; Schiffer, CA; Stamberg, J; Stone, RM; Vardiman, JW1
Bloomfield, CD; Carroll, AJ; Edwards, CG; Kolitz, JE; Larson, RA; Maharry, K; Marcucci, G; Mayer, RJ; Moore, JO; Mrózek, K; Pettenati, MJ; Powell, BL; Ruppert, AS; Schiffer, CA; Sterling, LJ; Vardiman, JW1
Amrein, PC; Dodge, RK; Godfrey, S; Kolitz, J; Lee, EJ; Moore, JO; Powell, B; Robert, F; Schiffer, CA1
Allen, SL; Amrein, PC; George, SL; Lee, EJ; Paciucci, PA; Schiffer, CA1
George, SL; Peterson, BL; Potthoff, RF1
Belasco, JB; Ettinger, LJ; Evans, AE; Higgins, GR; Jamin, DC; Rohrbaugh, TM; Ruccione, KS; Siegel, SE1

Trials

3 trial(s) available for diaziquone and Leukemia, Myeloid

ArticleYear
Outcome of induction and postremission therapy in younger adults with acute myeloid leukemia with normal karyotype: a cancer and leukemia group B study.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Jan-20, Volume: 23, Issue:3

    Topics: Acute Disease; Adolescent; Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Aziridines; Benzoquinones; Cyclophosphamide; Cytarabine; Daunorubicin; Etoposide; Female; Humans; Karyotyping; Leukemia, Myeloid; Male; Middle Aged; Mitoxantrone; Prognosis; Recurrence; Splenomegaly; Survival Analysis; Treatment Outcome

2005
Granulocyte-colony stimulating factor (filgrastim) accelerates granulocyte recovery after intensive postremission chemotherapy for acute myeloid leukemia with aziridinyl benzoquinone and mitoxantrone: Cancer and Leukemia Group B study 9022.
    Blood, 1997, Feb-01, Volume: 89, Issue:3

    Topics: Acute Disease; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Aziridines; Benzoquinones; Bone Marrow; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Granulocytes; Humans; Leukemia, Myeloid; Leukocyte Count; Male; Middle Aged; Mitoxantrone; Pilot Projects; Platelet Count; Recombinant Proteins; Remission Induction

1997
An evaluation of combinations of diaziquone, etoposide and mitoxantrone in the treatment of adults with relapsed or refractory acute myeloid leukemia: results of 8722, a randomized phase II study conducted by Cancer and Leukemia Group B.
    Leukemia, 1998, Volume: 12, Issue:2

    Topics: Acute Disease; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Aziridines; Benzoquinones; Etoposide; Female; Humans; Leukemia, Myeloid; Male; Middle Aged; Mitoxantrone

1998

Other Studies

3 other study(ies) available for diaziquone and Leukemia, Myeloid

ArticleYear
Prognostic factors and outcome of core binding factor acute myeloid leukemia patients with t(8;21) differ from those of patients with inv(16): a Cancer and Leukemia Group B study.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Aug-20, Volume: 23, Issue:24

    Topics: Acute Disease; Aged; Antineoplastic Combined Chemotherapy Protocols; Aziridines; Benzoquinones; Chromosome Aberrations; Cyclophosphamide; Cytarabine; Daunorubicin; Etoposide; Female; Humans; Leukemia, Myeloid; Male; Middle Aged; Mitoxantrone; Prognosis; Proportional Hazards Models; Prospective Studies; Remission Induction; Statistics, Nonparametric; Survival Analysis

2005
Detecting treatment-by-centre interaction in multi-centre clinical trials.
    Statistics in medicine, 2001, Jan-30, Volume: 20, Issue:2

    Topics: Aged; Antineoplastic Agents, Alkylating; Aziridines; Benzoquinones; Brain Neoplasms; Carmustine; Computer Simulation; Glioma; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Leukemia, Myeloid; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Remission Induction; Statistics as Topic

2001
Phase I clinical evaluation of diaziquone in childhood cancer.
    Cancer treatment reports, 1985, Volume: 69, Issue:3

    Topics: Adolescent; Age Factors; Aziridines; Azirines; Benzoquinones; Bone Marrow; Child; Child, Preschool; Drug Evaluation; Female; Hemoglobins; Humans; Infant; Leukemia, Lymphoid; Leukemia, Myeloid; Leukocyte Count; Liver; Male; Neoplasms; Platelet Count

1985